Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Instil Bio Analyst Ratings and Price Targets | NASDAQ:TIL | Benzinga
Instil Bio Inc has a consensus price target of $63.5 based on the ratings of 9 analysts. The high is $180 issued by Baird on September 16, 2024. The low is $2 issued by Morgan Stanley on December 12, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 5, 2025, May 23, 2025, and May 22, 2025, respectively. With an average price target of $118.33 between HC Wainwright & Co., there's an implied 320.67% upside for Instil Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jefferies
Baird
Truist Securities
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Instil Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/05/2025 | Buy Now | 344.37% | HC Wainwright & Co. | Mitchell Kapoor46% | $125 → $125 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2025 | Buy Now | — | JMP Securities | Reni Benjamin48% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 05/23/2025 | Buy Now | 344.37% | HC Wainwright & Co. | Mitchell Kapoor46% | $105 → $125 | Maintains | Buy | Get Alert |
| 05/22/2025 | Buy Now | 273.27% | HC Wainwright & Co. | Mitchell Kapoor46% | $110 → $105 | Maintains | Buy | Get Alert |
| 03/05/2025 | Buy Now | 291.04% | HC Wainwright & Co. | Mitchell Kapoor46% | $110 → $110 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | Buy Now | — | JMP Securities | Chris Muller50% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 01/07/2025 | Buy Now | 84.86% | Jefferies | Kelly Shi43% | $11 → $52 | Upgrade | Hold → Buy | Get Alert |
| 11/18/2024 | Buy Now | 291.04% | HC Wainwright & Co. | Mitchell Kapoor46% | $110 → $110 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | Buy Now | 291.04% | HC Wainwright & Co. | Mitchell Kapoor46% | $120 → $110 | Maintains | Buy | Get Alert |
| 11/04/2024 | Buy Now | — | JMP Securities | Reni Benjamin48% | — | Initiates | → Market Perform | Get Alert |
| 09/17/2024 | Buy Now | 326.59% | HC Wainwright & Co. | Mitchell Kapoor46% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 09/16/2024 | Buy Now | 326.59% | HC Wainwright & Co. | Mitchell Kapoor46% | $40 → $120 | Maintains | Buy | Get Alert |
| 09/16/2024 | Buy Now | 539.89% | Baird | Jack Allen 37% | $180 → $180 | Reiterates | Outperform → Outperform | Get Alert |
| 09/13/2024 | Buy Now | 539.89% | Baird | Jack Allen 37% | $32 → $180 | Maintains | Outperform | Get Alert |
| 09/12/2024 | Buy Now | 42.2% | HC Wainwright & Co. | Mitchell Kapoor46% | $25 → $40 | Maintains | Buy | Get Alert |
| 08/23/2024 | Buy Now | -11.13% | HC Wainwright & Co. | Mitchell Kapoor46% | $18 → $25 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | -36.01% | HC Wainwright & Co. | Mitchell Kapoor46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | -36.01% | HC Wainwright & Co. | Mitchell Kapoor46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 13.76% | Baird | Jack Allen 37% | $54 → $32 | Maintains | Outperform | Get Alert |
| 04/12/2024 | Buy Now | -60.9% | Jefferies | Kelly Shi43% | $5 → $11 | Downgrade | Buy → Hold | Get Alert |
| 03/25/2024 | Buy Now | -36.01% | HC Wainwright & Co. | Mitchell Kapoor46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 01/22/2024 | Buy Now | -36.01% | HC Wainwright & Co. | Mitchell Kapoor46% | $2 → $18 | Maintains | Buy | Get Alert |
| 01/19/2024 | Buy Now | 91.97% | Baird | Jack Allen 37% | → $54 | Reiterates | Outperform → Outperform | Get Alert |
| 01/17/2024 | Buy Now | 91.97% | Baird | Jack Allen 37% | $100 → $54 | Maintains | Outperform | Get Alert |
| 11/14/2023 | Buy Now | -92.89% | HC Wainwright & Co. | Mitchell Kapoor46% | → $2 | Reiterates | Buy → Buy | Get Alert |
| 08/17/2023 | Buy Now | -92.89% | HC Wainwright & Co. | Mitchell Kapoor46% | → $2 | Reiterates | Buy → Buy | Get Alert |
| 06/29/2023 | Buy Now | -92.89% | HC Wainwright & Co. | Mitchell Kapoor46% | → $2 | Initiates | → Buy | Get Alert |
| 04/05/2023 | Buy Now | -78.67% | Truist Securities | Asthika Goonewardene43% | → $6 | Reinstates | → Hold | Get Alert |
| 12/12/2022 | Buy Now | -92.89% | Morgan Stanley | Vikram Purohit39% | $6 → $2 | Maintains | Equal-Weight | Get Alert |
| 11/17/2022 | Buy Now | -50.23% | Baird | Jack Allen 37% | $24 → $14 | Maintains | Outperform | Get Alert |
| 11/01/2022 | Buy Now | -78.67% | Morgan Stanley | Vikram Purohit39% | $8 → $6 | Maintains | Equal-Weight | Get Alert |
| 11/01/2022 | Buy Now | -14.68% | Baird | Jack Allen 37% | $31 → $24 | Maintains | Outperform | Get Alert |
| 11/01/2022 | Buy Now | — | Cowen & Co. | Yaron Werber37% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/06/2022 | Buy Now | 10.2% | Baird | Jack Allen 37% | $34 → $31 | Maintains | Outperform | Get Alert |
| 08/24/2022 | Buy Now | -71.56% | Morgan Stanley | Vikram Purohit39% | $9 → $8 | Maintains | Equal-Weight | Get Alert |
| 08/23/2022 | Buy Now | -43.12% | Truist Securities | Robyn Karnauskas54% | $25 → $16 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Instil Bio (TIL) stock?
The latest price target for Instil Bio (NASDAQ:TIL) was reported by HC Wainwright & Co. on June 5, 2025. The analyst firm set a price target for $125.00 expecting TIL to rise to within 12 months (a possible 344.37% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Instil Bio (TIL)?
The latest analyst rating for Instil Bio (NASDAQ:TIL) was provided by HC Wainwright & Co., and Instil Bio reiterated their buy rating.
When was the last upgrade for Instil Bio (TIL)?
The last upgrade for Instil Bio Inc happened on January 7, 2025 when Jefferies raised their price target to $52. Jefferies previously had a hold for Instil Bio Inc.
When was the last downgrade for Instil Bio (TIL)?
The last downgrade for Instil Bio Inc happened on April 12, 2024 when Jefferies changed their price target from $5 to $11 for Instil Bio Inc.
When is the next analyst rating going to be posted or updated for Instil Bio (TIL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on June 5, 2025 so you should expect the next rating to be made available sometime around June 5, 2026.
Is the Analyst Rating Instil Bio (TIL) correct?
While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a reiterated with a price target of $125.00 to $125.00. The current price Instil Bio (TIL) is trading at is $28.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
